2026-2031 Global Therapeutic Nuclear Medicines Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region
HNY Research projects that the Therapeutic Nuclear Medicines market size will grow from 3904.1 Million USD in 2025 to 7549.52 Million USD by 2031, at an estimated CAGR of 11.62%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 752.32 Million USD, the Europe market size was 692.59 Million USD, and the Asia market size was 799.17 Million USD.
This report presents a detailed and holistic analysis of the global Therapeutic Nuclear Medicines market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Therapeutic Nuclear Medicines manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Cardinal Health
GE Healthcare
Lantheus Medical Imaging
Bayer
Eli Lilly
Bracco Imaging
Curium Pharma
Jubilant Pharmova
Aurobindo Pharma
Novartis
Siemens
NTP Radioisotopes
ANSTO
Polatom
China Isotope & Radiation
Dongcheng Pharma
Saide Bio
By Type
Radium-223
Lutetium-177
Iodine-131
Other
By Application
Thyroid
Bone Metastasis
Lymphoma
Other
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
For 2025 regional market size, the North America market size was 752.32 Million USD, the Europe market size was 692.59 Million USD, and the Asia market size was 799.17 Million USD.
This report presents a detailed and holistic analysis of the global Therapeutic Nuclear Medicines market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Therapeutic Nuclear Medicines manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Cardinal Health
GE Healthcare
Lantheus Medical Imaging
Bayer
Eli Lilly
Bracco Imaging
Curium Pharma
Jubilant Pharmova
Aurobindo Pharma
Novartis
Siemens
NTP Radioisotopes
ANSTO
Polatom
China Isotope & Radiation
Dongcheng Pharma
Saide Bio
By Type
Radium-223
Lutetium-177
Iodine-131
Other
By Application
Thyroid
Bone Metastasis
Lymphoma
Other
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
- The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
- To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
- Assess the production processes, major issues, and solutions to mitigate the development risk.
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
- Learn about the market strategies that are being adopted by leading respective organizations.
- To understand the future outlook and prospects for the market.
- Besides the standard structure reports, we also provide custom research according to specific requirements.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Therapeutic Nuclear Medicines Revenue
1.4 Market Analysis by Type
1.4.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type: 2026-2031
1.4.2 Radium-223
1.4.3 Lutetium-177
1.4.4 Iodine-131
1.4.5 Other
1.5 Market by Application
1.5.1 Global Therapeutic Nuclear Medicines Market Share by Application: 2026-2031
1.5.2 Thyroid
1.5.3 Bone Metastasis
1.5.4 Lymphoma
1.5.5 Other
1.6 Study Objectives
1.7 Overview of Global Therapeutic Nuclear Medicines Market
1.7.1 Global Therapeutic Nuclear Medicines Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines
2.2 Industry Chain Structure of Therapeutic Nuclear Medicines
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Therapeutic Nuclear Medicines Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2020-2025)
4 THERAPEUTIC NUCLEAR MEDICINES REGIONAL MARKET ANALYSIS
4.1 Therapeutic Nuclear Medicines Production by Regions
4.1.1 Global Therapeutic Nuclear Medicines Production by Regions (2020-2025)
4.1.2 Global Therapeutic Nuclear Medicines Revenue by Regions
4.2 Therapeutic Nuclear Medicines Consumption by Regions
4.3 North America Therapeutic Nuclear Medicines Market Analysis
4.3.1 North America Therapeutic Nuclear Medicines Production
4.3.2 North America Therapeutic Nuclear Medicines Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Therapeutic Nuclear Medicines Import and Export
4.4 East Asia Therapeutic Nuclear Medicines Market Analysis
4.4.1 East Asia Therapeutic Nuclear Medicines Production
4.4.2 East Asia Therapeutic Nuclear Medicines Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Therapeutic Nuclear Medicines Import & Export
4.5 Europe Therapeutic Nuclear Medicines Market Analysis
4.5.1 Europe Therapeutic Nuclear Medicines Production
4.5.2 Europe Therapeutic Nuclear Medicines Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Therapeutic Nuclear Medicines Import & Export
4.6 South Asia Therapeutic Nuclear Medicines Market Analysis
4.6.1 South Asia Therapeutic Nuclear Medicines Production
4.6.2 South Asia Therapeutic Nuclear Medicines Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Therapeutic Nuclear Medicines Import & Export
4.7 Southeast Asia Therapeutic Nuclear Medicines Market Analysis
4.7.1 Southeast Asia Therapeutic Nuclear Medicines Production
4.7.2 Southeast Asia Therapeutic Nuclear Medicines Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Therapeutic Nuclear Medicines Import & Export
4.8 Middle East Therapeutic Nuclear Medicines Market Analysis
4.8.1 Middle East Therapeutic Nuclear Medicines Production
4.8.2 Middle East Therapeutic Nuclear Medicines Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Therapeutic Nuclear Medicines Import & Export
4.9 Africa Therapeutic Nuclear Medicines Market Analysis
4.9.1 Africa Therapeutic Nuclear Medicines Production
4.9.2 Africa Therapeutic Nuclear Medicines Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Therapeutic Nuclear Medicines Import & Export
4.10 Oceania Therapeutic Nuclear Medicines Market Analysis
4.10.1 Oceania Therapeutic Nuclear Medicines Production
4.10.2 Oceania Therapeutic Nuclear Medicines Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Therapeutic Nuclear Medicines Import & Export
4.11 South America Therapeutic Nuclear Medicines Market Analysis
4.11.1 South America Therapeutic Nuclear Medicines Production
4.11.2 South America Therapeutic Nuclear Medicines Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Therapeutic Nuclear Medicines Import & Export
5 THERAPEUTIC NUCLEAR MEDICINES SALES MARKET BY TYPE (2020-2031)
5.1 Global Therapeutic Nuclear Medicines Historic Market Size by Type (2020-2025)
5.2 Global Therapeutic Nuclear Medicines Forecasted Market Size by Type (2026-2031)
6 THERAPEUTIC NUCLEAR MEDICINES CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Therapeutic Nuclear Medicines Historic Market Size by Application (2020-2025)
6.2 Global Therapeutic Nuclear Medicines Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN THERAPEUTIC NUCLEAR MEDICINES BUSINESS
7.1 Cardinal Health
7.1.1 Cardinal Health Company Profile
7.1.2 Cardinal Health Therapeutic Nuclear Medicines Product Specification
7.1.3 Cardinal Health Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 GE Healthcare
7.2.1 GE Healthcare Company Profile
7.2.2 GE Healthcare Therapeutic Nuclear Medicines Product Specification
7.2.3 GE Healthcare Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Lantheus Medical Imaging
7.3.1 Lantheus Medical Imaging Company Profile
7.3.2 Lantheus Medical Imaging Therapeutic Nuclear Medicines Product Specification
7.3.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Bayer
7.4.1 Bayer Company Profile
7.4.2 Bayer Therapeutic Nuclear Medicines Product Specification
7.4.3 Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Eli Lilly
7.5.1 Eli Lilly Company Profile
7.5.2 Eli Lilly Therapeutic Nuclear Medicines Product Specification
7.5.3 Eli Lilly Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Bracco Imaging
7.6.1 Bracco Imaging Company Profile
7.6.2 Bracco Imaging Therapeutic Nuclear Medicines Product Specification
7.6.3 Bracco Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Curium Pharma
7.7.1 Curium Pharma Company Profile
7.7.2 Curium Pharma Therapeutic Nuclear Medicines Product Specification
7.7.3 Curium Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Jubilant Pharmova
7.8.1 Jubilant Pharmova Company Profile
7.8.2 Jubilant Pharmova Therapeutic Nuclear Medicines Product Specification
7.8.3 Jubilant Pharmova Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Company Profile
7.9.2 Aurobindo Pharma Therapeutic Nuclear Medicines Product Specification
7.9.3 Aurobindo Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Novartis
7.10.1 Novartis Company Profile
7.10.2 Novartis Therapeutic Nuclear Medicines Product Specification
7.10.3 Novartis Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Siemens
7.11.1 Siemens Company Profile
7.11.2 Siemens Therapeutic Nuclear Medicines Product Specification
7.11.3 Siemens Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 NTP Radioisotopes
7.12.1 NTP Radioisotopes Company Profile
7.12.2 NTP Radioisotopes Therapeutic Nuclear Medicines Product Specification
7.12.3 NTP Radioisotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 ANSTO
7.13.1 ANSTO Company Profile
7.13.2 ANSTO Therapeutic Nuclear Medicines Product Specification
7.13.3 ANSTO Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.14 Polatom
7.14.1 Polatom Company Profile
7.14.2 Polatom Therapeutic Nuclear Medicines Product Specification
7.14.3 Polatom Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.15 China Isotope & Radiation
7.15.1 China Isotope & Radiation Company Profile
7.15.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Specification
7.15.3 China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.16 Dongcheng Pharma
7.16.1 Dongcheng Pharma Company Profile
7.16.2 Dongcheng Pharma Therapeutic Nuclear Medicines Product Specification
7.16.3 Dongcheng Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.17 Saide Bio
7.17.1 Saide Bio Company Profile
7.17.2 Saide Bio Therapeutic Nuclear Medicines Product Specification
7.17.3 Saide Bio Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Therapeutic Nuclear Medicines (2026-2031)
8.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines (2026-2031)
8.3 Global Forecasted Price of Therapeutic Nuclear Medicines (2020-2031)
8.4 Global Forecasted Production of Therapeutic Nuclear Medicines by Region (2026-2031)
8.4.1 North America Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.3 Europe Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.7 Africa Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.9 South America Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Therapeutic Nuclear Medicines by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.2 East Asia Market Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.3 Europe Market Forecasted Consumption of Therapeutic Nuclear Medicines by Countriy
9.4 South Asia Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.5 Southeast Asia Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.6 Middle East Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.7 Africa Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.8 Oceania Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.9 South America Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.10 Rest of the world Forecasted Consumption of Therapeutic Nuclear Medicines by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Therapeutic Nuclear Medicines Revenue
1.4 Market Analysis by Type
1.4.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type: 2026-2031
1.4.2 Radium-223
1.4.3 Lutetium-177
1.4.4 Iodine-131
1.4.5 Other
1.5 Market by Application
1.5.1 Global Therapeutic Nuclear Medicines Market Share by Application: 2026-2031
1.5.2 Thyroid
1.5.3 Bone Metastasis
1.5.4 Lymphoma
1.5.5 Other
1.6 Study Objectives
1.7 Overview of Global Therapeutic Nuclear Medicines Market
1.7.1 Global Therapeutic Nuclear Medicines Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines
2.2 Industry Chain Structure of Therapeutic Nuclear Medicines
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Therapeutic Nuclear Medicines Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2020-2025)
4 THERAPEUTIC NUCLEAR MEDICINES REGIONAL MARKET ANALYSIS
4.1 Therapeutic Nuclear Medicines Production by Regions
4.1.1 Global Therapeutic Nuclear Medicines Production by Regions (2020-2025)
4.1.2 Global Therapeutic Nuclear Medicines Revenue by Regions
4.2 Therapeutic Nuclear Medicines Consumption by Regions
4.3 North America Therapeutic Nuclear Medicines Market Analysis
4.3.1 North America Therapeutic Nuclear Medicines Production
4.3.2 North America Therapeutic Nuclear Medicines Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Therapeutic Nuclear Medicines Import and Export
4.4 East Asia Therapeutic Nuclear Medicines Market Analysis
4.4.1 East Asia Therapeutic Nuclear Medicines Production
4.4.2 East Asia Therapeutic Nuclear Medicines Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Therapeutic Nuclear Medicines Import & Export
4.5 Europe Therapeutic Nuclear Medicines Market Analysis
4.5.1 Europe Therapeutic Nuclear Medicines Production
4.5.2 Europe Therapeutic Nuclear Medicines Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Therapeutic Nuclear Medicines Import & Export
4.6 South Asia Therapeutic Nuclear Medicines Market Analysis
4.6.1 South Asia Therapeutic Nuclear Medicines Production
4.6.2 South Asia Therapeutic Nuclear Medicines Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Therapeutic Nuclear Medicines Import & Export
4.7 Southeast Asia Therapeutic Nuclear Medicines Market Analysis
4.7.1 Southeast Asia Therapeutic Nuclear Medicines Production
4.7.2 Southeast Asia Therapeutic Nuclear Medicines Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Therapeutic Nuclear Medicines Import & Export
4.8 Middle East Therapeutic Nuclear Medicines Market Analysis
4.8.1 Middle East Therapeutic Nuclear Medicines Production
4.8.2 Middle East Therapeutic Nuclear Medicines Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Therapeutic Nuclear Medicines Import & Export
4.9 Africa Therapeutic Nuclear Medicines Market Analysis
4.9.1 Africa Therapeutic Nuclear Medicines Production
4.9.2 Africa Therapeutic Nuclear Medicines Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Therapeutic Nuclear Medicines Import & Export
4.10 Oceania Therapeutic Nuclear Medicines Market Analysis
4.10.1 Oceania Therapeutic Nuclear Medicines Production
4.10.2 Oceania Therapeutic Nuclear Medicines Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Therapeutic Nuclear Medicines Import & Export
4.11 South America Therapeutic Nuclear Medicines Market Analysis
4.11.1 South America Therapeutic Nuclear Medicines Production
4.11.2 South America Therapeutic Nuclear Medicines Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Therapeutic Nuclear Medicines Import & Export
5 THERAPEUTIC NUCLEAR MEDICINES SALES MARKET BY TYPE (2020-2031)
5.1 Global Therapeutic Nuclear Medicines Historic Market Size by Type (2020-2025)
5.2 Global Therapeutic Nuclear Medicines Forecasted Market Size by Type (2026-2031)
6 THERAPEUTIC NUCLEAR MEDICINES CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Therapeutic Nuclear Medicines Historic Market Size by Application (2020-2025)
6.2 Global Therapeutic Nuclear Medicines Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN THERAPEUTIC NUCLEAR MEDICINES BUSINESS
7.1 Cardinal Health
7.1.1 Cardinal Health Company Profile
7.1.2 Cardinal Health Therapeutic Nuclear Medicines Product Specification
7.1.3 Cardinal Health Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 GE Healthcare
7.2.1 GE Healthcare Company Profile
7.2.2 GE Healthcare Therapeutic Nuclear Medicines Product Specification
7.2.3 GE Healthcare Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Lantheus Medical Imaging
7.3.1 Lantheus Medical Imaging Company Profile
7.3.2 Lantheus Medical Imaging Therapeutic Nuclear Medicines Product Specification
7.3.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Bayer
7.4.1 Bayer Company Profile
7.4.2 Bayer Therapeutic Nuclear Medicines Product Specification
7.4.3 Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Eli Lilly
7.5.1 Eli Lilly Company Profile
7.5.2 Eli Lilly Therapeutic Nuclear Medicines Product Specification
7.5.3 Eli Lilly Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Bracco Imaging
7.6.1 Bracco Imaging Company Profile
7.6.2 Bracco Imaging Therapeutic Nuclear Medicines Product Specification
7.6.3 Bracco Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Curium Pharma
7.7.1 Curium Pharma Company Profile
7.7.2 Curium Pharma Therapeutic Nuclear Medicines Product Specification
7.7.3 Curium Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Jubilant Pharmova
7.8.1 Jubilant Pharmova Company Profile
7.8.2 Jubilant Pharmova Therapeutic Nuclear Medicines Product Specification
7.8.3 Jubilant Pharmova Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Company Profile
7.9.2 Aurobindo Pharma Therapeutic Nuclear Medicines Product Specification
7.9.3 Aurobindo Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Novartis
7.10.1 Novartis Company Profile
7.10.2 Novartis Therapeutic Nuclear Medicines Product Specification
7.10.3 Novartis Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Siemens
7.11.1 Siemens Company Profile
7.11.2 Siemens Therapeutic Nuclear Medicines Product Specification
7.11.3 Siemens Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 NTP Radioisotopes
7.12.1 NTP Radioisotopes Company Profile
7.12.2 NTP Radioisotopes Therapeutic Nuclear Medicines Product Specification
7.12.3 NTP Radioisotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 ANSTO
7.13.1 ANSTO Company Profile
7.13.2 ANSTO Therapeutic Nuclear Medicines Product Specification
7.13.3 ANSTO Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.14 Polatom
7.14.1 Polatom Company Profile
7.14.2 Polatom Therapeutic Nuclear Medicines Product Specification
7.14.3 Polatom Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.15 China Isotope & Radiation
7.15.1 China Isotope & Radiation Company Profile
7.15.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Specification
7.15.3 China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.16 Dongcheng Pharma
7.16.1 Dongcheng Pharma Company Profile
7.16.2 Dongcheng Pharma Therapeutic Nuclear Medicines Product Specification
7.16.3 Dongcheng Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.17 Saide Bio
7.17.1 Saide Bio Company Profile
7.17.2 Saide Bio Therapeutic Nuclear Medicines Product Specification
7.17.3 Saide Bio Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Therapeutic Nuclear Medicines (2026-2031)
8.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines (2026-2031)
8.3 Global Forecasted Price of Therapeutic Nuclear Medicines (2020-2031)
8.4 Global Forecasted Production of Therapeutic Nuclear Medicines by Region (2026-2031)
8.4.1 North America Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.3 Europe Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.7 Africa Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.9 South America Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Therapeutic Nuclear Medicines Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Therapeutic Nuclear Medicines by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.2 East Asia Market Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.3 Europe Market Forecasted Consumption of Therapeutic Nuclear Medicines by Countriy
9.4 South Asia Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.5 Southeast Asia Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.6 Middle East Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.7 Africa Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.8 Oceania Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.9 South America Forecasted Consumption of Therapeutic Nuclear Medicines by Country
9.10 Rest of the world Forecasted Consumption of Therapeutic Nuclear Medicines by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES
Key Players Covered: Ranking by Therapeutic Nuclear Medicines Revenue 2020-2025
Global Therapeutic Nuclear Medicines Market Size by Type: 2026-2031
Global Therapeutic Nuclear Medicines Market Size by Application: 2026-2031
Therapeutic Nuclear Medicines Production Rank and Commercial Production Date of Key Manufacturers
Global Therapeutic Nuclear Medicines Manufacturing Plants Distribution and Commercial Production Date
Global Therapeutic Nuclear Medicines Production Capacity by Manufacturers
Global Therapeutic Nuclear Medicines Production by Manufacturers (2020-2025)
Global Therapeutic Nuclear Medicines Production Market Share by Manufacturers (2020-2025)
Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2020-2025)
Global Market Therapeutic Nuclear Medicines Average Price of Key Manufacturers (2020-2025)
Manufacturers Therapeutic Nuclear Medicines Production Sites and Area Served
Manufacturers Therapeutic Nuclear Medicines Product Type
Global Therapeutic Nuclear Medicines Production by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Production Market Share by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Revenue by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Consumption by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Consumption Market Share by Regions (2020-2025)
Key Therapeutic Nuclear Medicines Players Sales Volume in North America
North America Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in East Asia
East Asia Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Europe
Europe Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in South Asia
South Asia Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Southeast Asia
Southeast Asia Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Middle East
Middle East Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Africa
Africa Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Oceania
Oceania Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in South America
South America Therapeutic Nuclear Medicines Production, Consumption Import and Export
Global Therapeutic Nuclear Medicines Market Size by Type (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2020-2025)
Global Therapeutic Nuclear Medicines Forecasted Market Size by Type (2026-2031)
Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2026-2031)
Global Therapeutic Nuclear Medicines Market Size by Application (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2020-2025)
Global Therapeutic Nuclear Medicines Forecasted Market Size by Application (2026-2031)
Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2026-2031)
Cardinal Health Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
GE Healthcare Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Eli Lilly Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Bracco Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Curium Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Jubilant Pharmova Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Aurobindo Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Novartis Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Siemens Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
NTP Radioisotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
ANSTO Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Polatom Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Dongcheng Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Saide Bio Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Therapeutic Nuclear Medicines Production Forecast by Region (2026-2031)
Global Therapeutic Nuclear Medicines Sales Volume Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Revenue Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Revenue Market Share Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Price Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Consumption Volume Forecast by Application (2026-2031)
Global Therapeutic Nuclear Medicines Consumption Value Forecast by Application (2026-2031)
North America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
East Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Europe Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
South Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Southeast Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Middle East Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Africa Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Oceania Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
South America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Rest of the world Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Therapeutic Nuclear Medicines Market Share by Type: 2025 VS 2031
Radium-223 Features
Lutetium-177 Features
Iodine-131 Features
Other Features
Global Therapeutic Nuclear Medicines Market Share by Application: 2025 VS 2031
Thyroid Case Studies
Bone Metastasis Case Studies
Lymphoma Case Studies
Other Case Studies
Therapeutic Nuclear Medicines Report Years Considered
Global Therapeutic Nuclear Medicines Market Status and Outlook (2020-2031)
North America Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
East Asia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Europe Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
South Asia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
South America Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Middle East Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Africa Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Oceania Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
South America Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Global Therapeutic Nuclear Medicines Revenue (2020-2031)
Global Therapeutic Nuclear Medicines Production Capacity (2020-2031)
Global Therapeutic Nuclear Medicines Production (2020-2031)
Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines in 2025
Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Industry Chain Structure of Therapeutic Nuclear Medicines
Global Therapeutic Nuclear Medicines Production Market Share by Regions in 2025
Global Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2025
North America Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
North America Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
East Asia Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
East Asia Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Europe Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Europe Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
South Asia Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
South Asia Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Southeast Asia Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Southeast Asia Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Middle East Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Middle East Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Africa Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Africa Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Oceania Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Oceania Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
South America Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
South America Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Cardinal Health Therapeutic Nuclear Medicines Product Specification
GE Healthcare Therapeutic Nuclear Medicines Product Specification
Lantheus Medical Imaging Therapeutic Nuclear Medicines Product Specification
Bayer Therapeutic Nuclear Medicines Product Specification
Eli Lilly Therapeutic Nuclear Medicines Product Specification
Bracco Imaging Therapeutic Nuclear Medicines Product Specification
Curium Pharma Therapeutic Nuclear Medicines Product Specification
Jubilant Pharmova Therapeutic Nuclear Medicines Product Specification
Aurobindo Pharma Therapeutic Nuclear Medicines Product Specification
Novartis Therapeutic Nuclear Medicines Product Specification
Siemens Therapeutic Nuclear Medicines Product Specification
NTP Radioisotopes Therapeutic Nuclear Medicines Product Specification
ANSTO Therapeutic Nuclear Medicines Product Specification
Polatom Therapeutic Nuclear Medicines Product Specification
China Isotope & Radiation Therapeutic Nuclear Medicines Product Specification
Dongcheng Pharma Therapeutic Nuclear Medicines Product Specification
Saide Bio Therapeutic Nuclear Medicines Product Specification
Global Therapeutic Nuclear Medicines Production Capacity Growth Rate Forecast (2026-2031)
Global Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Global Therapeutic Nuclear Medicines Price and Trend Forecast (2020-2031)
North America Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
North America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
East Asia Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
East Asia Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Europe Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Europe Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
South Asia Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
South Asia Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Southeast Asia Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Middle East Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Middle East Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Africa Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Africa Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Oceania Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Oceania Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
South America Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
South America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Rest of the World Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Rest of the World Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
North America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
East Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Europe Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
South Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Southeast Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Middle East Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Africa Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Oceania Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
South America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Rest of the world Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
Key Players Covered: Ranking by Therapeutic Nuclear Medicines Revenue 2020-2025
Global Therapeutic Nuclear Medicines Market Size by Type: 2026-2031
Global Therapeutic Nuclear Medicines Market Size by Application: 2026-2031
Therapeutic Nuclear Medicines Production Rank and Commercial Production Date of Key Manufacturers
Global Therapeutic Nuclear Medicines Manufacturing Plants Distribution and Commercial Production Date
Global Therapeutic Nuclear Medicines Production Capacity by Manufacturers
Global Therapeutic Nuclear Medicines Production by Manufacturers (2020-2025)
Global Therapeutic Nuclear Medicines Production Market Share by Manufacturers (2020-2025)
Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2020-2025)
Global Market Therapeutic Nuclear Medicines Average Price of Key Manufacturers (2020-2025)
Manufacturers Therapeutic Nuclear Medicines Production Sites and Area Served
Manufacturers Therapeutic Nuclear Medicines Product Type
Global Therapeutic Nuclear Medicines Production by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Production Market Share by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Revenue by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Consumption by Regions (2020-2025)
Global Therapeutic Nuclear Medicines Consumption Market Share by Regions (2020-2025)
Key Therapeutic Nuclear Medicines Players Sales Volume in North America
North America Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in East Asia
East Asia Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Europe
Europe Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in South Asia
South Asia Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Southeast Asia
Southeast Asia Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Middle East
Middle East Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Africa
Africa Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in Oceania
Oceania Therapeutic Nuclear Medicines Production, Consumption Import and Export
Key Therapeutic Nuclear Medicines Players Sales Volume in South America
South America Therapeutic Nuclear Medicines Production, Consumption Import and Export
Global Therapeutic Nuclear Medicines Market Size by Type (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2020-2025)
Global Therapeutic Nuclear Medicines Forecasted Market Size by Type (2026-2031)
Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2026-2031)
Global Therapeutic Nuclear Medicines Market Size by Application (2020-2025)
Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2020-2025)
Global Therapeutic Nuclear Medicines Forecasted Market Size by Application (2026-2031)
Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2026-2031)
Cardinal Health Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
GE Healthcare Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Eli Lilly Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Bracco Imaging Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Curium Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Jubilant Pharmova Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Aurobindo Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Novartis Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Siemens Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
NTP Radioisotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
ANSTO Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Polatom Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Dongcheng Pharma Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Saide Bio Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Therapeutic Nuclear Medicines Production Forecast by Region (2026-2031)
Global Therapeutic Nuclear Medicines Sales Volume Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Revenue Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Revenue Market Share Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Sales Price Forecast by Type (2026-2031)
Global Therapeutic Nuclear Medicines Consumption Volume Forecast by Application (2026-2031)
Global Therapeutic Nuclear Medicines Consumption Value Forecast by Application (2026-2031)
North America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
East Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Europe Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
South Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Southeast Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Middle East Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Africa Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Oceania Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
South America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Rest of the world Therapeutic Nuclear Medicines Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Therapeutic Nuclear Medicines Market Share by Type: 2025 VS 2031
Radium-223 Features
Lutetium-177 Features
Iodine-131 Features
Other Features
Global Therapeutic Nuclear Medicines Market Share by Application: 2025 VS 2031
Thyroid Case Studies
Bone Metastasis Case Studies
Lymphoma Case Studies
Other Case Studies
Therapeutic Nuclear Medicines Report Years Considered
Global Therapeutic Nuclear Medicines Market Status and Outlook (2020-2031)
North America Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
East Asia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Europe Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
South Asia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
South America Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Middle East Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Africa Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Oceania Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
South America Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2020-2031)
Global Therapeutic Nuclear Medicines Revenue (2020-2031)
Global Therapeutic Nuclear Medicines Production Capacity (2020-2031)
Global Therapeutic Nuclear Medicines Production (2020-2031)
Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines in 2025
Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Industry Chain Structure of Therapeutic Nuclear Medicines
Global Therapeutic Nuclear Medicines Production Market Share by Regions in 2025
Global Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2025
North America Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
North America Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
East Asia Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
East Asia Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Europe Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Europe Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
South Asia Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
South Asia Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Southeast Asia Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Southeast Asia Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Middle East Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Middle East Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Africa Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Africa Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Oceania Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
Oceania Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
South America Therapeutic Nuclear Medicines Production Growth Rate 2020-2025
South America Therapeutic Nuclear Medicines Revenue Growth Rate 2020-2025
Cardinal Health Therapeutic Nuclear Medicines Product Specification
GE Healthcare Therapeutic Nuclear Medicines Product Specification
Lantheus Medical Imaging Therapeutic Nuclear Medicines Product Specification
Bayer Therapeutic Nuclear Medicines Product Specification
Eli Lilly Therapeutic Nuclear Medicines Product Specification
Bracco Imaging Therapeutic Nuclear Medicines Product Specification
Curium Pharma Therapeutic Nuclear Medicines Product Specification
Jubilant Pharmova Therapeutic Nuclear Medicines Product Specification
Aurobindo Pharma Therapeutic Nuclear Medicines Product Specification
Novartis Therapeutic Nuclear Medicines Product Specification
Siemens Therapeutic Nuclear Medicines Product Specification
NTP Radioisotopes Therapeutic Nuclear Medicines Product Specification
ANSTO Therapeutic Nuclear Medicines Product Specification
Polatom Therapeutic Nuclear Medicines Product Specification
China Isotope & Radiation Therapeutic Nuclear Medicines Product Specification
Dongcheng Pharma Therapeutic Nuclear Medicines Product Specification
Saide Bio Therapeutic Nuclear Medicines Product Specification
Global Therapeutic Nuclear Medicines Production Capacity Growth Rate Forecast (2026-2031)
Global Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Global Therapeutic Nuclear Medicines Price and Trend Forecast (2020-2031)
North America Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
North America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
East Asia Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
East Asia Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Europe Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Europe Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
South Asia Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
South Asia Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Southeast Asia Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Middle East Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Middle East Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Africa Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Africa Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Oceania Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Oceania Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
South America Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
South America Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
Rest of the World Therapeutic Nuclear Medicines Production Growth Rate Forecast (2026-2031)
Rest of the World Therapeutic Nuclear Medicines Revenue Growth Rate Forecast (2026-2031)
North America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
East Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Europe Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
South Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Southeast Asia Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Middle East Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Africa Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Oceania Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
South America Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Rest of the world Therapeutic Nuclear Medicines Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
